It is noteworthy that most of these attempts are based on the notion that CD8+ T cells are the main effector arm against cancer and that the purpose of myeloid cell activation is to support T cell-mediated killing (Ricketts et al., 2021; Bercovici et al., 2019). Here, CD8A is linked to cancer.